MedTrace Logo

Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

NCT02299310 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-12-02

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of valsartan and perindopril on HOMA-IR Index in patients with chronic kidney disease.

Conditions

Interventions

DRUG

Valsartan

Valsartan 80mg/tablet, 1 tablet once daily (crossover)

DRUG

Perindopril

Perindopril 4mg/tablet, 1 tablet once daily (crossover)

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • RiBao Wei, Master · Department of Nephrology, Chinese PLA General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299310 on ClinicalTrials.gov